These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interactions of 5-hydroxytryptamine and narcotic analgesics on dog intestine in vivo. de Oliveira LF, Sollero L. Pharmacology; 1973; 10(5):291-7. PubMed ID: 4764535 [No Abstract] [Full Text] [Related]
6. Pharmacologic analysis of chronotropic and inotropic responses to 5-hydroxytryptamine in the dog heart. Chiba S. Jpn J Pharmacol; 1977 Oct; 27(5):727-34. PubMed ID: 22772 [No Abstract] [Full Text] [Related]
7. Studies of changes in breathing and blood pressure accompanying a cardiogenic hypertensive chemoreflex compared in conscious and anesthetized dogs. Hageman GR, James TN, Urthaler F. Am Heart J; 1983 Sep; 106(3):547-53. PubMed ID: 6881029 [Abstract] [Full Text] [Related]
8. A cardiogenic hypertensive chemoreflex. James TN. Anesth Analg; 1989 Nov; 69(5):633-46. PubMed ID: 2679232 [Abstract] [Full Text] [Related]
9. Further studies of the pharmacology of the pyloric region. Analysis of the effects of intra-arterial histamine, serotonin, phenyldiguanide, morphine, and other drugs on the antrum and duodenal bulb. Daniel EE. Can J Physiol Pharmacol; 1966 Nov; 44(6):981-1019. PubMed ID: 4381915 [No Abstract] [Full Text] [Related]
11. On the mechanism of the coronary dilator effect of serotonin in the dog. Mena MA, Vidrio H. Eur J Pharmacol; 1976 Mar; 36(1):1-5. PubMed ID: 1261588 [Abstract] [Full Text] [Related]
16. Evidence for a presynaptic inhibitory action of 5-hydroxytryptamine on sympathetic neurotransmission to the myocardium. Martinez AA, Lokhandwala MF. Eur J Pharmacol; 1980 May 16; 63(4):303-11. PubMed ID: 6248349 [Abstract] [Full Text] [Related]